Mobeus supports IVF clinic expansion

http://www.bourn-hall-clinic.co.uk/
http://www.bourn-hall-clinic.co.uk/

Mobeus is pleased to announce an investment to support the geographic expansion of Bourn Bioscience Limited, trading as Bourn Hall Clinic.  An initial £3.5 million investment for a minority shareholding is supplemented by a commitment to invest significant follow-on finance.

Bourn Hall Clinic owns and operates the internationally renowned Bourn Hall, near Cambridge; the first IVF clinic in the world.  The clinic was founded in 1980 by Robert Edwards and Patrick Steptoe, the IVF pioneers whose work led to the birth of the first test-tube baby, Louise Brown, in 1978.  Since its formation, Bourn Hall Clinic has been responsible for the birth of over 15,000 children.

Today the company comprises three full service IVF clinics in Cambridge, Colchester and Norwich, supported by a number of satellite units based in NHS hospitals and its own satellite unit in Wickford.  Bourn Hall Clinic is the largest independent fertility services provider in the East of England, employing 120 staff and delivering over 2,500 IVF cycles per annum.

The UK market for fertility services has grown significantly in recent years, driven by increasing acceptance and awareness of IVF procedures, favourable demographics and improved success rates.  Bourn Hall Clinic is looking to continue expanding its geographic footprint, leveraging its strong and respected brand and reputation.

Greg Blin, Investment Manager at Mobeus commented: “We are delighted to support an excellent team and to be involved with the Bourn Hall brand which has a strong reputation, built on its long heritage and expertise in the field of IVF.  We believe the business represents a first class platform for growth in an attractive and expanding niche of the healthcare sector.”

– Ends –

Issued by Mobeus Equity Partners LLP, of 30 Haymarket, London SW1Y 4EX, registered in England & Wales number OC320577, authorised and regulated by the Financial Conduct Authority, number 456538. This material is for information only and does not constitute an offer to buy or sell an investment nor does it solicit any such invitation. The information contained in this email is believed to be accurate at the date of publication but no representation or warranty stated or implied is made or given by any person as to its accuracy or completeness and no responsibility or liability is accepted for any such information or opinion.

Return to previous page >